Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
This analysis points to fund families that consistently stood out in index fund history, helping you recognize dominant players over time.
25,021 articlesA leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Cavco stock rose about 9% over the past year even as a large fund pulled roughly $12 million in Cavco shares. This ar...
Illinois has floated a plan to fix its long-broken alcohol tax system. This article explains what the proposal actual...
This weekend, dive into 10 investing reads that translate to real-world gains—from fee awareness to tax planning and ...
Chevron has kept its promise to shareholders with steady cash returns. Discover how 16 quarters of returns totaling o...
Bitcoin has pulled back sharply from recent highs, leaving both new and seasoned investors wondering what comes next....
The Dow crosses the 50,000 threshold for the first time, rising over 1,200 points in a single session. Analysts call ...
Opendoor Technologies stock down discordant headlines have traders wondering if a rebound is possible. This article b...
During 13F season, big investors reveal shifts in their portfolios. This piece explains the move, why Microsoft was f...
A public disagreement rumor meets real-world finance. Discover how the idea that there’s no feud can translate into p...
Hedge funds linked to Millennium Management are expanding IVV positions as markets wobble, intensifying chatter aroun...
A sizzling 12.7% ultra-high-yield dividend can boost income, but safety matters. This guide shows how to screen, vali...